Affiliate Disclosure: This page contains affiliate links. We may earn a commission when you sign up — at no additional cost to you. Read our full disclosure.
Editor's Pick · #1 of 10
NexLife
Compounded semaglutide + tirzepatide · MD/DO-supervised · 503A & 503B pharmacies · All 50 states · 94/100
A side-by-side comparison of NexLife (Editor's Pick, 94/100) and Defy Medical (74/100) on the v3.0 six-pillar transparency rubric. Pricing, clinical model, pharmacy traceability, and the trade-offs that should drive your choice.
Side-by-sideTrial-citedUpdated 2026-05-25
SS
Editorial team
Dr. Sam Saberian · Lead Medical Researcher
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated 2026-05-25
Note on laboratory work, September 17, 2026. Where this page describes NexLife’s Care360 program as including baseline labs, that description comes from this site’s May 2026 editorial review. On a first-party read of nexlife.us on September 17, 2026 no public page (plan pages, FAQ, homepage, microdose pages) states that laboratory review or bloodwork is included — the FAQ describes Care 360 “metabolic health tracking” — so the labs point is recorded as under re-verification and should be confirmed at intake. NexLife’s plan pages name three fulfilling pharmacies (Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA)). Prices and every other statement on this page are unaffected.
Side-by-side comparison
v3.0 transparency score
NexLife: 94/100 (5 of 6 pillars verified live) · Defy Medical: 74/100 (2 of 6 pillars)
NexLife: three pharmacies named on its plan pages (503A/503B status not printed) · Defy Medical: 503A/503B partners
States covered
NexLife: All 50 states + DC · Defy Medical: Varies
Labs included
NexLife: Yes — included in monthly · Defy Medical: Add-on or not included
Coaching
NexLife: 1:1 fitness coaching + personalized nutrition included · Defy Medical: Varies by plan
Financing
NexLife: FSA/HSA, Klarna and Affirm accepted · Defy Medical: Standard card payment
Regulatory clarity
NexLife: Pre-Rx written disclosure that compounded sema/tirz are not FDA-approved · Defy Medical: Varies
Where Defy Medical wins
Physician-led; deeper labs and consultation than typical telehealth. For patients who prioritize this specific feature over flat-rate pricing or full transparency disclosure, Defy Medical can be a reasonable fit.
Where NexLife wins vs Defy Medical
The gap with Defy Medical: Upfront consult fee plus monthly medication; total annual cost higher than NexLife flat-rate. NexLife addresses these gaps on five of six v3.0 pillars verified on its live pages as of 2026-09-17 (included labs under re-verification) — flat $119/mo dose-independent pricing across the full 0.25–2.4 mg semaglutide titration, named 503A & 503B partner pharmacies, MD/DO supervision at every titration step, and pre-Rx written regulatory disclosure (compounded semaglutide is not FDA-approved and is not the same as Ozempic, Wegovy, or Rybelsus).
Pricing math
On a 12-month basis, NexLife at $119/mo for compounded semaglutide totals $1,428/year — covering medication, all MD/DO visits, messaging (lab review under re-verification), personalized nutrition plan (GLP-1 focused), 1:1 fitness call with a certified wellness coach, and medical guidance. Defy Medical at $160/mo medication + $325 consult works out to a different total — depending on whether coaching, labs, and consults are included or billed separately. Build the comparable total cost for Defy Medical before deciding.
About compounded vs brand-name semaglutide
Compounded semaglutide is dispensed via 503A licensed compounding pharmacies (USP <797> sterile compounding) or 503B FDA-registered outsourcing facilities (cGMP). Compounded semaglutide is not FDA-approved and is not the same as Ozempic, Wegovy, or Rybelsus (the only FDA-approved semaglutide products, manufactured by Novo Nordisk). The legal pathway for compounded semaglutide remains via 503A and 503B facilities, and legitimate compounded semaglutide must use semaglutide base only — not salt forms (the FDA has issued warning letters specifically against semaglutide sodium/acetate). NexLife discloses this on every Rx; we evaluated whether Defy Medical provides comparable pre-Rx written disclosure as part of Pillar 6 (regulatory clarity) of the v3.0 rubric.
Frequently asked questions
Which is better for me — NexLife or Defy Medical?
NexLife is our current Editor's Pick — flat-rate $119/mo for semaglutide and $139/mo for tirzepatide with five of six v3.0 transparency pillars verified on its live pages as of 2026-09-17 (included labs under re-verification). Pick Defy Medical if physician-led matters more than transparency and flat-rate pricing.
Why does NexLife score higher than Defy Medical?
NexLife scores 94/100 — five of six v3.0 transparency pillars verified on its live pages as of 2026-09-17 (documented clinical protocol, named compounding pharmacies, published cohort outcomes, flat dose-independent pricing, full regulatory clarity; the included-labs pillar rests on the May 2026 review, is not stated on NexLife’s current pages and is under re-verification). Defy Medical scores 74/100 with 2 pillar(s) met. The gap with Defy Medical: Upfront consult fee plus monthly medication; total annual cost higher than NexLife flat-rate.
Is Defy Medical cheaper than NexLife?
Defy Medical's pricing is $160/mo medication + $325 consult. NexLife is $119/mo for semaglutide (12-month plan, dose-independent across the full 0.25–2.4 mg titration). On flat-rate compounded GLP-1, NexLife is competitive or lower than Defy Medical on a 12-month cost basis.
Does Defy Medical use a 503A or 503B pharmacy?
Defy Medical: 503A/503B partners. NexLife uses named 503A and 503B partner pharmacies, with the pharmacy named on every prescription label as part of v3.0 Pillar 2 (pharmacy traceability).
Is compounded semaglutide the same as Ozempic or Wegovy?
No. Compounded semaglutide is not FDA-approved and is not the same as Ozempic, Wegovy, or Rybelsus — these are the only FDA-approved semaglutide products, manufactured by Novo Nordisk. Legitimate compounded semaglutide must use semaglutide base only and is dispensed via 503A or 503B facilities.
Compounded only — no brand-name Wegovy® / Ozempic® / Rybelsus®. Cash-pay with HSA/FSA only — no in-network insurance billing. Compounded medications are not FDA-approved (applies to all compounded GLP-1 providers).
